ADOPTION OF CHATGPT AS A DRUG INFORMATION RESOURCE: A COMMUNITY-BASED STUDY AMONG PHARMACISTS

Muchukota Sushma

Eurasian Journal of Critical Care - 2026;8(1):27-34

Aditya Bangalore Institute of Pharmacy Education and Research (ABIPER), India

 

Background: Access to accurate and timely drug information is essential for safe and effective pharmacy practice. However, conventional drug information resources are often limited by high costs, restricted accessibility, and time-intensive search processes. Artificial intelligence-based tools such as ChatGPT-4 offer rapid and conversational access to drug-related information, yet evidence regarding their real-world utilization in pharmacy practice remains limited. Methods: This community-based cross-sectional study evaluated the extent, purpose, and perceived impact of ChatGPT-4 use among pharmacists. A total of 300 pharmacists from community, hospital, and academic settings were included. Data were collected using a validated questionnaire assessing frequency of use, types of queries, perceived accuracy, and associated challenges. Results: Overall, 72% of pharmacists reported using ChatGPT-4 for drug information, with the highest utilization observed in community pharmacy settings. The most common queries included dosage adjustments (41%), drug-drug interactions (28%), and adverse drug reaction management (22%). A majority of participants perceived ChatGPT-4 as a time-saving tool (68%), while 40% rated its accuracy as moderate to high. Additionally, 55% reported increased confidence in patient counseling. However, 32% expressed concerns regarding reliability and the lack of cited sources. Conclusion: ChatGPT-4 is widely used among pharmacists and is perceived as a useful and time-efficient tool for drug information. Despite its benefits, concerns regarding reliability and source transparency highlight the need for cautious use and further validation studies before routine integration into pharmacy practice.